Statistics for <i>LRP1B</i> mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types.

Total visits

views
<i>LRP1B</i> mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. 74

Total visits per month

views
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0

File Visits

views
iLRP1Bi mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types.pdf 32